Modulation of Human Cells by Virulent Francisella tularensis
Modulation of Human Cells by Virulent Francisella tularensis
批准号:
8745527
负责人:
Catharine Bosio
金额:
$50.16万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AerosolsAnti-Inflammatory AgentsAnti-inflammatoryAttenuatedBacteriaBiologicalBreathingCarbohydratesCell physiologyCellsCover-upDataDefectDendritic CellsDevelopmentDiseaseFrancisellaFrancisella tularensisGoalsHumanImmune responseImmune systemImmunosuppressionImmunosuppressive AgentsIndividualInfectionInflammatoryInflammatory ResponseInvadedLaboratoriesLipidsMediatingMembraneMicrobeMusNatural ImmunityO AntigensPlayProteinsPublishingResearchRoleRouteSecondary toSentinelSignal PathwaySignal TransductionStimulusStructureSurfaceSymptomsTimeTularemiaUSSRUnited StatesVirulenceVirulentadaptive immunitycapsulecarbohydrate structurecell killingcytokinemacrophagemortalitymutantnovel therapeuticsnovel vaccinespathogenpreventprogramsreceptorresponsetransmission processvectorweapons
中文摘要
摘要:土拉菌是土拉菌病的病原体,可通过多种途径感染人类,包括媒介传播。然而,吸入这种细菌以及由此产生的肺炎土拉菌病是最危险的一种疾病。这是由于潜伏期短(3-5天)、非特异性症状和未经治疗个体的高死亡率(大于80%)。此外,美国和前苏联都将土拉菌武器化,使其成为一种可行的生物武器。尽管全球范围内对土拉菌进行了80多年的研究,但人们对这种细菌与宿主的动态相互作用知之甚少,尤其是在气溶胶感染之后。
英文摘要
Summary: Francisella tularensis, the causative agent for tularemia, can infect humans by a number of routes, including vector-borne transmission. However, it is inhalation of the bacterium, and the resulting pneumonic tularemia, that represents the most dangerous form of disease. This is due to the short incubation time (3-5 days), non-specific symptoms, and a high mortality rate (greater than 80%) in untreated individuals. Furthermore, F. tularensis has been weaponized by both the United States and the former Soviet Union making it a viable candidate for use as a biological weapon. Despite over 80 years of research on F. tularensis around the world, very little is understood about the dynamic interaction of this bacterium with the host, especially following aerosol infection.
My laboratory has established that, similarly to murine cells, human dendritic cells and macrophages are acutely susceptible to infection with F. tularensis, but fail to produce pro-inflammatory cytokines or undergo maturation. Further, virulent F. tularensis actively interferes with the ability of human DC and macrophages to respond to secondary stimuli. Understanding the mechanism by which F. tularensis actively suppresses DC and macrophage function is a central directive of my laboratory. We are tackling this directive in two different ways.
First, we are analyzing the role Francisella lipids play in mediating anti-inflammatory responses. Structures present on the surface of bacteria are the first components encountered by the host cell. Thus, it is possible that, in the context of F. tularensis infections, these structures contribute to the early, rapid suppression of human dendritic cells. Bacterial lipids represent one such structure. We recently published that lipids isolated from virulent, but not attenuated F. tularensis, potently suppress inflammatory responses in human dendritic cells and macrophages. Further, we identified the specific signal transduction proteins modulated by Francisella lipids. We are currently identifying the specific lipid(s) responsible for this suppression and the mechanism by which they interfere with human dendritic cell functions.
Second, we are exploring the role of carbohydrates associated with the outer surface of F. tularensis in directing immunosuppressive programs in human cells. The major outer surface carbohydrate structure of F. tularensis is the O-Antigen (O-Ag) associated with LPS. Typically O-Ag is thought to simply cover up proteins present on the bacterial surface that could stimulate an inflammatory response. However, we have preliminary data which demonstrates that the O-Ag directly inhibits pro-inflammatory responses in human cells. Utilizing mutants with specific defects in O-Ag synthesis, we are currently identifying the specific receptors and host signaling pathways modulated by F. tularensis O-Ag to initiate an anti-inflammatory program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Immunity to Pulmonary Infections
-
批准号:10272123
-
项目类别:
-
资助金额:$153.3万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:7592364
-
项目类别:
-
资助金额:$142.25万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:10014174
-
项目类别:
-
资助金额:$72.55万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pulmonary Infections
-
批准号:10692102
-
项目类别:
-
资助金额:$131.17万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Effect of SARS-CoV-2 on host metabolism and its influence on innate and adaptive immunity
-
批准号:10927941
-
项目类别:
-
资助金额:$11.27万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:7964623
-
项目类别:
-
资助金额:$103.21万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
CAP:Cationic DNA Liposome^Microbial Complexes as Broad Spectrum Antimicrobials
-
批准号:8556063
-
项目类别:
-
资助金额:$10.41万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:8946416
-
项目类别:
-
资助金额:$75.4万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:8556006
-
项目类别:
-
资助金额:$43.19万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:9161654
-
项目类别:
-
资助金额:$35.13万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:8157079
-
项目类别:
-
资助金额:$68.43万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:8336307
-
项目类别:
-
资助金额:$72.9万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:8336235
-
项目类别:
-
资助金额:$106.28万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:9566707
-
项目类别:
-
资助金额:$69.43万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:7732663
-
项目类别:
-
资助金额:$133.61万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pneumonic Tularemia
-
批准号:8555936
-
项目类别:
-
资助金额:$64.78万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:7964751
-
项目类别:
-
资助金额:$68.81万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Immunity to Pulmonary Infections
-
批准号:10927811
-
项目类别:
-
资助金额:$142.62万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Modulation of Human Cells by Virulent Francisella tularensis
-
批准号:10927845
-
项目类别:
-
资助金额:$35.65万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
Effect of SARS-CoV-2 on host metabolism and its influence on innate and adaptive immunity
-
批准号:10692237
-
项目类别:
-
资助金额:$19.23万
-
财政年份:--
-
负责人:Catharine Bosio
-
依托单位:
海外基金